logo
15:40 Dec 05

Wanbury Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
238.75
-7.10 (-2.89%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Wanbury Ltd. Financials

Wanbury Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
238.75
-7.10 (-2.89%)
15:40 Dec 05
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

52/100
Affordable Valuation

Technical

39/100
Technically Neutral

Strength

7

Weakness

6

Opportunity

0

Threats

0

51.50 %

ROE %

7.37 %

ROA %

14.37

EPS

18.09

BVPS

5.09 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
511.19 499.65 575.65 599.51 629.82
Operating Expenses +
475.87 476.48 505.65 523.2 541.79
Raw Material
325.07 273.46 306.52 292.96 301.36
Increase Decrease in Cost
-24.79 29.13 -3.89 1.51 2.19
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
74.81 81 86.92 104.24 107.77
Miscellaneous Expenses
141.06 124.85 150.7 154.65 130.47
Operating Profit
35.32 23.17 70 76.31 88.03
Other Income
1.51 0.91 2.99 3.49 4.66
Depreciation
11.45 12.38 13.03 13.31 13.65
Interest
20.61 21.39 29.18 36.95 36.9
Profit before tax and exceptio..
4.76 -9.69 30.78 29.55 42.14
Exceptional Items
76.37 -0.59 25.56 0 0
PBT
81.13 -10.29 56.34 29.55 42.14
Provision for Taxation
-0.35 0.11 0.38 -0.98 -0.86
Net Profit
81.47 -10.4 55.96 30.53 42.99
NET Profit after MI
81.47 -10.4 55.96 30.53 42.99
EPS
25.29 -3.18 17.1 9.32 13.12
Operating Profit Margin (%)
6.91 4.64 12.16 12.73 13.98
Net Profit Margin (%)
15.94 -2.08 9.72 5.09 6.83

Wanbury Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 39.60 39.60 39.80 39.80 39.80 39.80
FII 0.80 1.60 1.60 0.80 1.00 0.20
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 59.60 58.80 58.60 59.40 59.20 60.00
Shareholder Shares Holding %
Research 360 logo
Download Our App On: